Serum biomarkers of cardiovascular complications in COVID-19

Serum biomarkers of cardiovascular complications in COVID-19

The coronavirus disease 2019 (COVID-19) affects not only the respiratory system, but also the cardiovascular system in 20-28% of cases, causing endothelial dysfunction, vasculitis, hyper- and hypocoagulation, myocarditis, endothelial dysfunction and other adverse effects. The presence of cardiovascu...

Full description

Saved in:
Bibliographic Details
Main Authors: R. M. Gumerov, D. F. Gareeva, P. A. Davtyan, R. F. Rakhimova, T. I. Musin, Sh. Z. Zagidullin, A. E. Pushkareva, M. R. Plotnikova, V. Sh. Ishmetov, V. N. Pavlov, L. J. Motloch, N. Sh. Zagidullin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2021-07-01
Series:Российский кардиологический журнал
Subjects:
covid-19
sars-cov-2
biomarkers
cardiovascular events
risk stratification
Online Access:https://russjcardiol.elpub.ru/jour/article/view/4456
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://russjcardiol.elpub.ru/jour/article/view/4456

Similar Items